Medicare's actuaries expect the drug Leqembi to cost the traditional Medicare program around $550 million in 2024 and the entire Medicare program $3.5 billion in 2025.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
